Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study-Reference-Cited by-同舟云学术

Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study

Published:2023-06 Issue:3 Volume:8 Page:101569
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Le Cesne A.,Chevreau C.,Perrin C.,Italiano A.,Hervieu A.,Blay J.Y.,Piperno-Neumann S.,Saada-Bouzid E.,Bertucci F.,Firmin N.,Kalbacher E.,Narciso B.,Schiffler C.,Yara S.,Jimenez M.,Bouvier C.,Vidal V.,Chabaud S.,Duffaud F.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference22 articles.

1. Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up;Strauss;Ann Oncol,2021

2. Chordoma

3. Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group;Stacchiotti;Ann Oncol,2017

4. A pediatric phase I trial and pharmacokinetic (PK) study of sunitinib: a Children’s Oncology group Phase I Consortium trial;DuBois;J Clin Oncol,2008

5. Efficacy and safety of sorafenib in a subset of patients with soft tissue sarcoma from a Phase II randomized discontinuation trial;Pacey;Invest New Drugs,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase 2 study of a brachyury‐targeting vaccine in combination with radiation therapy for the treatment of advanced chordoma;Cancer;2024-07-10

2. The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocol;Neurosurgical Focus;2024-05

3. MicroRNA‑1224 inhibits cell proliferation by downregulating CBX3 expression in chordoma;Oncology Letters;2024-04-10

4. Unraveling molecular signatures in rare bone tumors and navigating the cancer pathway landscapes for targeted therapeutics;Critical Reviews in Oncology/Hematology;2024-04

5. Chordoma: A Comprehensive Systematic Review of Clinical Trials;Cancers;2023-12-11